The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

For the Paediatric Rheumatology International Trials Organisation (PRINTO)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Dutch language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 209 JIA patients (14.3% systemic, 39.7% oligoarticular, 25.8% RF negative polyarthritis, 20.2% other categories) and 107 healthy children were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Dutch version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.

Original languageEnglish
Pages (from-to)139-146
Number of pages8
JournalRheumatology International
Volume38
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Juvenile Arthritis
Psychometrics
Parents
Reproducibility of Results
Arthritis
Reading
Healthy Volunteers

Keywords

  • Disease status
  • Functional ability
  • Health-related quality of life
  • JAMAR
  • Juvenile idiopathic arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). / For the Paediatric Rheumatology International Trials Organisation (PRINTO).

In: Rheumatology International, Vol. 38, 01.04.2018, p. 139-146.

Research output: Contribution to journalArticle

For the Paediatric Rheumatology International Trials Organisation (PRINTO) 2018, 'The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)', Rheumatology International, vol. 38, pp. 139-146. https://doi.org/10.1007/s00296-018-3971-y
For the Paediatric Rheumatology International Trials Organisation (PRINTO). The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 2018 Apr 1;38:139-146. https://doi.org/10.1007/s00296-018-3971-y
For the Paediatric Rheumatology International Trials Organisation (PRINTO). / The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). In: Rheumatology International. 2018 ; Vol. 38. pp. 139-146.
@article{44805512183f4d6e829b5da748b5a500,
title = "The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)",
abstract = "The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Dutch language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 209 JIA patients (14.3{\%} systemic, 39.7{\%} oligoarticular, 25.8{\%} RF negative polyarthritis, 20.2{\%} other categories) and 107 healthy children were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Dutch version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.",
keywords = "Disease status, Functional ability, Health-related quality of life, JAMAR, Juvenile idiopathic arthritis",
author = "{For the Paediatric Rheumatology International Trials Organisation (PRINTO)} and Nico Wulffraat and Sylvia Kamphuis and Swart, {Joost F.} and Sebastiaan Vastert and {Van Dijkhuizen}, Pieter and {van Pelt}, Philomine and {van Dijk-Hummelman}, Annette and Alessandro Consolaro and Francesca Bovis and Nicolino Ruperto",
year = "2018",
month = "4",
day = "1",
doi = "10.1007/s00296-018-3971-y",
language = "English",
volume = "38",
pages = "139--146",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

AU - For the Paediatric Rheumatology International Trials Organisation (PRINTO)

AU - Wulffraat, Nico

AU - Kamphuis, Sylvia

AU - Swart, Joost F.

AU - Vastert, Sebastiaan

AU - Van Dijkhuizen, Pieter

AU - van Pelt, Philomine

AU - van Dijk-Hummelman, Annette

AU - Consolaro, Alessandro

AU - Bovis, Francesca

AU - Ruperto, Nicolino

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Dutch language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 209 JIA patients (14.3% systemic, 39.7% oligoarticular, 25.8% RF negative polyarthritis, 20.2% other categories) and 107 healthy children were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Dutch version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.

AB - The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Dutch language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 209 JIA patients (14.3% systemic, 39.7% oligoarticular, 25.8% RF negative polyarthritis, 20.2% other categories) and 107 healthy children were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Dutch version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.

KW - Disease status

KW - Functional ability

KW - Health-related quality of life

KW - JAMAR

KW - Juvenile idiopathic arthritis

UR - http://www.scopus.com/inward/record.url?scp=85045238225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045238225&partnerID=8YFLogxK

U2 - 10.1007/s00296-018-3971-y

DO - 10.1007/s00296-018-3971-y

M3 - Article

C2 - 29637344

AN - SCOPUS:85045238225

VL - 38

SP - 139

EP - 146

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

ER -